Imax price target raised to $42 from $40 at Benchmark

Benchmark raised the firm’s price target on Imax (IMAX) to $42 from $40 and keeps a Buy rating on the shares following the company’s investor day, which the firm says “underscored a powerful multi-year growth outlook,” supported by record box office momentum, rising market share, and “exceptional slate visibility” through 2028.